Quantitative proteomic characterization of the lung extracellular matrix in chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis
- PMID: 29501846
- DOI: 10.1016/j.jprot.2018.02.027
Quantitative proteomic characterization of the lung extracellular matrix in chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis
Abstract
Remodeling of the extracellular matrix (ECM) is a common feature in lung diseases such as chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis (IPF). Here, we applied a sequential tissue extraction strategy to describe disease-specific remodeling of human lung tissue in disease, using end-stages of COPD and IPF. Our strategy was based on quantitative comparison of the disease proteomes, with specific focus on the matrisome, using data-independent acquisition and targeted data analysis (SWATH-MS). Our work provides an in-depth proteomic characterization of human lung tissue during impaired tissue remodeling. In addition, we show important quantitative and qualitative effects of the solubility of matrisome proteins. COPD was characterized by a disease-specific increase in ECM regulators, metalloproteinase inhibitor 3 (TIMP3) and matrix metalloproteinase 28 (MMP-28), whereas for IPF, impairment in cell adhesion proteins, such as collagen VI and laminins, was most prominent. For both diseases, we identified increased levels of proteins involved in the regulation of endopeptidase activity, with several proteins belonging to the serpin family. The established human lung quantitative proteome inventory and the construction of a tissue-specific protein assay library provides a resource for future quantitative proteomic analyses of human lung tissues. SIGNIFICANCE: We present a sequential tissue extraction strategy to determine changes in extractability of matrisome proteins in end-stage COPD and IPF compared to healthy control tissue. Extensive quantitative analysis of the proteome changes of the disease states revealed altered solubility of matrisome proteins involved in ECM regulators and cell-ECM communication. The results highlight disease-specific remodeling mechanisms associated with COPD and IPF.
Keywords: COPD; IPF; Lung tissue; Matrisome; Quantitative proteomics; SWATH-MS.
Copyright © 2018 Elsevier B.V. All rights reserved.
Similar articles
-
SWATH mass spectrometry as a tool for quantitative profiling of the matrisome.J Proteomics. 2018 Oct 30;189:11-22. doi: 10.1016/j.jprot.2018.02.026. Epub 2018 Mar 1. J Proteomics. 2018. PMID: 29501709 Free PMC article.
-
Regional and disease specific human lung extracellular matrix composition.Biomaterials. 2023 Feb;293:121960. doi: 10.1016/j.biomaterials.2022.121960. Epub 2022 Dec 24. Biomaterials. 2023. PMID: 36580718 Free PMC article.
-
Matrisome Properties of Scaffolds Direct Fibroblasts in Idiopathic Pulmonary Fibrosis.Int J Mol Sci. 2019 Aug 17;20(16):4013. doi: 10.3390/ijms20164013. Int J Mol Sci. 2019. PMID: 31426504 Free PMC article.
-
The Role of miRNAs in Extracellular Matrix Repair and Chronic Fibrotic Lung Diseases.Cells. 2021 Jul 6;10(7):1706. doi: 10.3390/cells10071706. Cells. 2021. PMID: 34359876 Free PMC article. Review.
-
The extracellular matrix - the under-recognized element in lung disease?J Pathol. 2016 Dec;240(4):397-409. doi: 10.1002/path.4808. Epub 2016 Oct 28. J Pathol. 2016. PMID: 27623753 Free PMC article. Review.
Cited by
-
What is the need and why is it time for innovative models for understanding lung repair and regeneration?Front Pharmacol. 2023 Feb 13;14:1130074. doi: 10.3389/fphar.2023.1130074. eCollection 2023. Front Pharmacol. 2023. PMID: 36860303 Free PMC article. Review.
-
Identification of Hub Genes in Idiopathic Pulmonary Fibrosis and NSCLC Progression:Evidence From Bioinformatics Analysis.Front Genet. 2022 Apr 11;13:855789. doi: 10.3389/fgene.2022.855789. eCollection 2022. Front Genet. 2022. PMID: 35480306 Free PMC article.
-
Matrix Metalloproteinases in Chronic Obstructive Pulmonary Disease.Int J Mol Sci. 2023 Feb 14;24(4):3786. doi: 10.3390/ijms24043786. Int J Mol Sci. 2023. PMID: 36835197 Free PMC article. Review.
-
MMP-1 and ADAM10 as Targets for Therapeutic Intervention in Idiopathic Pulmonary Fibrosis.ACS Pharmacol Transl Sci. 2022 Jul 18;5(8):548-554. doi: 10.1021/acsptsci.2c00050. eCollection 2022 Aug 12. ACS Pharmacol Transl Sci. 2022. PMID: 35983283 Free PMC article.
-
Small molecule proteomics quantifies differences between normal and fibrotic pulmonary extracellular matrices.Chin Med J (Engl). 2020 May 20;133(10):1192-1202. doi: 10.1097/CM9.0000000000000754. Chin Med J (Engl). 2020. PMID: 32433051 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical